Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin for Alcohol Dependence
NCT00391716Phase 2Completed
- Sponsor
- Scripps Research
- Start
- Feb 2004
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of gabapentin in alcohol dependence (3 arms), sponsored by Scripps Research. Primary endpoints: Rate of Complete Abstinence at 12 weeks and Rate of No Heavy Drinking at 12 weeks. Started Feb 2004; status: completed.
02
Drugs
gabapentin
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on NCT00391716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00391716.